2021
14-3-3 proteins inactivate DAPK2 by promoting its dimerization and protecting key regulatory phosphosites
HORVATH, M., O. PETRVALSKA, P. HERMAN, V. OBSILOVA, T. OBSIL et. al.Základní údaje
Originální název
14-3-3 proteins inactivate DAPK2 by promoting its dimerization and protecting key regulatory phosphosites
Autoři
HORVATH, M., O. PETRVALSKA, P. HERMAN, V. OBSILOVA a T. OBSIL
Vydání
COMMUNICATIONS BIOLOGY, 2021, 2399-3642
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
10600 1.6 Biological sciences
Stát vydavatele
Německo
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 6.548
Kód RIV
RIV/00216224:14740/21:00124530
Organizační jednotka
Středoevropský technologický institut
UT WoS
000686777300004
Klíčová slova anglicky
INTRINSICALLY DISORDERED PROTEINSSERINE/THREONINE KINASESTRUCTURAL BASISBINDINGINHIBITIONAPOPTOSISRAFDIFFERENTIATIONRECOGNITIONACTIVATION
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 18. 5. 2022 15:00, Mgr. Pavla Foltynová, Ph.D.
Anotace
V originále
Death-associated protein kinase 2 (DAPK2) is a CaM-regulated Ser/Thr protein kinase, involved in apoptosis, autophagy, granulocyte differentiation and motility regulation, whose activity is controlled by autoinhibition, autophosphorylation, dimerization and interaction with scaffolding proteins 14-3-3. However, the structural basis of 14-3-3-mediated DAPK2 regulation remains unclear. Here, we structurally and biochemically characterize the full-length human DAPK2:14-3-3 complex by combining several biophysical techniques. The results from our X-ray crystallographic analysis revealed that Thr369 phosphorylation at the DAPK2 C terminus creates a high-affinity canonical mode III 14-3-3-binding motif, further enhanced by the diterpene glycoside Fusicoccin A. Moreover, concentration-dependent DAPK2 dimerization is disrupted by Ca2+/CaM binding and stabilized by 14-3-3 binding in solution, thereby protecting the DAPK2 inhibitory autophosphorylation site Ser318 against dephosphorylation and preventing Ca2+/CaM binding. Overall, our findings provide mechanistic insights into 14-3-3-mediated DAPK2 inhibition and highlight the potential of the DAPK2:14-3-3 complex as a target for anti-inflammatory therapies. Horvath et al. structurally and biochemically characterize the full-length human DAPK2-14-3-3 complex to investigate the effects of binding to DAPK2 on its dimerization, activation by dephosphorylation of Ser318, and Ca2+/calmodulin binding. Their results provide mechanistic insights into 14- 3-3-mediated DAPK2 inhibition and highlight the potential of the DAPK2:14-3-3 complex as a target for anti-inflammatory therapies.
Návaznosti
90127, velká výzkumná infrastruktura |
|